| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Barchas JD | |
| Evans C | |||
| Berger PA | |||
| Elliott GR | |||
| P2860 | cites work | Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands | Q24561925 |
| Isolation and characterization of α-N-acetylβ-endorphin(1–26) from the rat posterior/intermediate pituitary lobe | Q70996545 | ||
| beta-Endorphin and schizophrenia | Q71231653 | ||
| beta-Endorphin. Intravenous infusion causes behavioral change in psychiatric inpatients | Q71231658 | ||
| Des-Tyr1-gamma-endorphin in schizophrenia | Q72445983 | ||
| Naloxone-induced reduction of schizophrenic symptoms A CASE REPORT | Q72533800 | ||
| Immunoreactive dynorphin-(1-8) and corticotropin- releasing factor in subpopulation of hypothalamic neurons | Q72542694 | ||
| Cerebrospinal fluid [Met5] enkephalin level in schizophrenics during treatment with naloxone | Q72564074 | ||
| A putative processing enzyme from aplysia that cleaves dynorphin A at the single arginine residue | Q72575102 | ||
| Behavioral change in a cancer patient following intrathecal beta- endorphin administration | Q72721616 | ||
| Behavioral and biological effects of acute beta-endorphin injection in schizophrenic and depressed patients | Q72877875 | ||
| Enkephalinase: Selective inhibitors and partial characterization | Q72896277 | ||
| Opiate binding properties of naturally occurring N- and C-Terminus modified beta-endorphins | Q72913152 | ||
| Differences in the post-translational processing of beta-endorphin in rat anterior and intermediate pituitary | Q70797473 | ||
| Long-Term Stress-Induced Analgesia and Activation of the Opiate System | Q70889330 | ||
| Metorphamide: isolation, structure, and biologic activity of an amidated opioid octapeptide from bovine brain | Q24614482 | ||
| Carboxypeptidase B activity from adrenal medulla — Is it involved in the processing of proenkephalin? | Q28260947 | ||
| Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors | Q28568270 | ||
| Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin | Q29617507 | ||
| Indication of an Antipsychotic Action of the Opiate Antagonist Naloxone | Q33176768 | ||
| Common precursor to corticotropins and endorphins | Q34019394 | ||
| Brain peptides: what, where, and why? | Q34054789 | ||
| The effects of naloxone in chronic schizophrenia | Q34055155 | ||
| Identification of two related pentapeptides from the brain with potent opiate agonist activity | Q34134593 | ||
| Opiate Receptor: Demonstration in Nervous Tissue | Q34216480 | ||
| Regional distribution of metorphamide in rat and guinea pig brain | Q34261657 | ||
| Isolation of melatonin and 5-methoxyindole-3-acetic acid from bovine pineal glands | Q34262263 | ||
| Nucleotide sequence of cloned cDNA for bovine corticotropin-β-lipotropin precursor | Q34634402 | ||
| Chemical determination of polypeptide hormones | Q35989114 | ||
| Immunohistochemical distribution of alpha-neo-endorphin/dynorphin neuronal systems in rat brain: evidence for colocalization | Q36295234 | ||
| Opiates and classical conditioning: selective abolition of conditioned responses by activation of opiate receptors within the central nervous system | Q36325391 | ||
| Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide | Q36380726 | ||
| Differential processing of prodynorphin and proenkephalin in specific regions of the rat brain. | Q37576387 | ||
| Immunohistochemical distribution of dynorphin B in rat brain: relation to dynorphin A and alpha-neo-endorphin systems | Q37604325 | ||
| Some Observations on the Opiate Peptides and Schizophrenia | Q37883825 | ||
| Medical Treatment of Mental Illness | Q38285281 | ||
| Behavioral Neurochemistry: Neuroregulators and Behavioral States | Q39189776 | ||
| Investigating the role of endogenous opioid peptides in psychiatric disorders | Q39249764 | ||
| Epidural beta-endorphin in treatment of pain | Q39565481 | ||
| Profound analgesic effects of beta-endorphin in man. | Q39572686 | ||
| Pain Relief by Intrathecally Applied Morphine in Man | Q39576361 | ||
| Stress-induced parallel changes in central opioid levels and pain responsiveness in the rat | Q40042683 | ||
| Behavioral Pharmacology of the Endorphins | Q40129565 | ||
| Identification of proopiomelanocortin neurones in rat hypothalamus by in situ cDNA-mRNA hybridization | Q40138875 | ||
| Adrenocorticotropin in Rat Brain: Immunocytochemical Localization in Cells and Axons | Q40148167 | ||
| Analysis of Pro-opiomelancortin Gene Structure and Function | Q40149451 | ||
| The Measurement of Endorphins in Body Fluids | Q40164366 | ||
| Evidence for two separate opiate peptide neuronal systems | Q40173205 | ||
| On βH-Leu5-Endorphin and Schizophrenia | Q40207931 | ||
| beta-Endorphin and naloxone in psychiatric patients: clinical and biological effects | Q40228299 | ||
| β-endorphin immunoreactivity in rat and human blood: Radioimmunoassay, comparative levels and physiological alterations | Q40254786 | ||
| Intravenous Naloxone Administration in Schizophrenia and Affective Illness | Q40776255 | ||
| The treatment of perceptual disturbances in schizophrenia with naloxone hydrochloride | Q40825593 | ||
| Effects of Naloxone on Schizophrenia: Reduction in Hallucinations in a Subpopulation of Subjects | Q40904803 | ||
| Improvement of Schizophrenic Patients Treated With Des-Tyr1]-γ-endorphin (DTγE) | Q41002533 | ||
| Endorphins in human cerebrospinal fluid: Clinical correlations to some psychotic states | Q41038923 | ||
| Short-term naloxone administration in schizophrenic and manic patients. A World Health Organization Collaborative Study | Q41532873 | ||
| Binding of 3H-β-endorphin to rat brain membranes: Characterization of opiate properties and interaction with ACTH | Q41549727 | ||
| Abolition of conditioned heart-rate responses in rabbits following central administration of [N-MePhe3, D-Pro4] morphiceptin | Q41588461 | ||
| Des-tyrosyl-gamma-endorphin in schizophrenia: a double-blind trial in 13 patients | Q41614798 | ||
| Antipsychotic properties of Des-enkephalin-gamma-endorphin in treatment of schizophrenic patients | Q41622379 | ||
| Plasma β-Endorphin Immunoreactivity in Schizophrenia | Q41760454 | ||
| Lack of effect on naloxone on schizophrenic symptoms | Q43617370 | ||
| Synthetic enkephalin analogue in treatment of schizophrenia | Q43696472 | ||
| The effect of hemodialysis on schizophrenia: a survey of patients with renal failure | Q43854279 | ||
| Hemodialysis in schizophrenia: three failures with chronic patients | Q44164377 | ||
| Measurement of total opioid peptides in rat brain and pituitary by radioimmunoassay directed at the alpha-N-acetyl derivative | Q44331514 | ||
| Synthetic N-dimethyl β-endorphin, a stabilized opioid peptide | Q44332160 | ||
| Yet another opioid peptide? | Q44352155 | ||
| Opioid peptides as neuroregulators: Potential areas for the study of genetic-behavioral mechanisms | Q44353065 | ||
| The use of hemodialysis in chronic schizophrenia | Q44433525 | ||
| Naloxone in chronic schizophrenia | Q45121580 | ||
| Neuromedin L: A novel mammalian tachykinin identified in porcine spinal cord | Q46848898 | ||
| Regional distribution of opiate receptor binding in monkey and human brain | Q48624600 | ||
| Effects of postmortem delay and temperature on neurotransmitter receptor binding in a rat model of the human autopsy process | Q48640809 | ||
| Plasma cortisol and beta-endorphin immunoreactivity in nonmajor and major depression | Q48679668 | ||
| Regional distribution of dynorphin and neo-endorphin peptides in rat brain, spinal cord, and pituitary | Q48722789 | ||
| Brain distributions of alpha-neo-endorphin and beta-neo-endorphin: evidence for regional processing differences | Q48896317 | ||
| Dynorphin1–8 and dynorphin1–9 are ligands for the κ-subtype of opiate receptor | Q48898826 | ||
| Predominance of the amino-terminal octapeptide fragment of dynorphin in rat brain regions | Q48898838 | ||
| Variants of alpha-melanocyte stimulating hormone in rat brain and pituitary evidence that acetylated alpha-MSH exists only in the intermediate lobe of pituitary. | Q48932936 | ||
| Acetylated and nonacetylated forms of β-endorphin in rat brain and pituitary | Q49132355 | ||
| Colocalization of alpha-neo-endorphin and dynorphin immunoreactivity in hypothalamic neurons | Q49132457 | ||
| Mood and behavioral effects of physostigmine on humans are accompanied by elevations in plasma beta-endorphin and cortisol. | Q51264925 | ||
| LOCALIZATION OF MELATONIN IN THE NERVOUS SYSTEM | Q51273903 | ||
| Beta-endorphin--induced changes in schizophrenic and depressed patients. | Q51284693 | ||
| Amino-acid sequence of the alpha-melanocyte-stimulating hormone. | Q51325926 | ||
| beta-Endorphin in obstetric analgesia. | Q51875688 | ||
| Plasma Immunoreactive β-Endorphin Levels in Depression | Q58391742 | ||
| β-endorphin and β-lipotropin plasma levels in chronic schizophrenia, primary affective disorders and secondary affective disorders | Q60690474 | ||
| C.S.F. beta-endorphin in schizophrenia | Q66702878 | ||
| Naloxone in schizophrenia: negative result | Q66703369 | ||
| Analgesia to pain stimuli in schizophrenics and its reversal by naltrexone | Q66872851 | ||
| Human EEG response to beta-endorphin | Q66872856 | ||
| Naloxone-induced reversal of schizophrenic hallucinations | Q66879304 | ||
| β-Endorphin-Like Immunoreactivity in Cerebrospinal Fluid and Plasma of Patients with Schizophrenia and Other Neuropsychiatric Disorders | Q66932545 | ||
| Effects of the Synthetic Analogue of Methionine Enkephalin FK 33-824 on Psychotic Symptoms | Q66932548 | ||
| beta-Endorphin hypersecretion in depression: possible cholinergic mechanisms | Q67243136 | ||
| Studies of beta-endorphin in psychiatric patients | Q67263187 | ||
| beta-Endorphin administration to acute schizophrenic patients: a double blind study | Q67263193 | ||
| Naloxone treatment for five days ineffective in schizophrenia. Neuroendocrine actions of the opiate antagonist | Q67300284 | ||
| Naxolone in amylobarbitone-responsive catatonia | Q67427466 | ||
| An oral opiate antagonist in chronic schizophrenia: a pilot study | Q67707217 | ||
| Identification of Pro-Opiomelanocortin-Derived Peptides in the Human Adrenal Medulla | Q70155471 | ||
| Interaction of opiate peptide and noradrenalin systems: light microscopic studies | Q70155778 | ||
| Des-tyrosine-gamma-endorphin administration in chronic schizophrenics. A preliminary report | Q70718277 | ||
| P433 | issue | 6 | |
| P921 | main subject | nerve tissue protein | Q6996861 |
| peptide | Q172847 | ||
| opioid | Q427523 | ||
| P304 | page(s) | 579-596 | |
| P577 | publication date | 1985-11-01 | |
| P1433 | published in | Yale Journal of Biology and Medicine | Q15709982 |
| P1476 | title | Peptide neuroregulators: the opioid system as a model | |
| P478 | volume | 58 |
Search more.